| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.935 | 0.001 | 0.935 | 5 Hydroxytryptamine 1E antagonist | 0.44 0.004 DBMET02583 0.621 0.003 DBMET02585 | ||
| 0.857 | 0.003 | 0.857 | 5 Hydroxytryptamine 1 agonist | 0.694 0.004 DBMET02583 0.7 0.004 DBMET02585 0.252 0.008 DBMET02584 | ||
| 0.813 | 0.001 | 0.813 | 5 Hydroxytryptamine 1D agonist | 0.251 0.002 DBMET02583 0.704 0.001 DBMET02585 | ||
| 0.794 | 0.002 | 0.794 | 5 Hydroxytryptamine 1B agonist | 0.623 0.002 DBMET02583 0.466 0.003 DBMET02585 0.29 0.004 DBMET02584 | ||
| 0.756 | 0.004 | 0.756 | 5 Hydroxytryptamine agonist | 0.459 0.005 DBMET02583 0.53 0.005 DBMET02585 0.086 0.038 DBMET02584 | ||
| 0.701 | 0.002 | 0.701 | 5 Hydroxytryptamine 5A antagonist | 0.077 0.025 DBMET02583 0.227 0.004 DBMET02585 | ||
| 0.696 | 0.002 | 0.696 | 5 Hydroxytryptamine 1D antagonist | 0.117 0.017 DBMET02583 0.317 0.004 DBMET02585 | ||
| 0.67 | 0.002 | 0.67 | 5 Hydroxytryptamine 5 antagonist | 0.065 0.031 DBMET02583 0.205 0.005 DBMET02585 | ||
| 0.585 | 0.003 | 0.585 | 5 Hydroxytryptamine 1B antagonist | 0.081 0.033 DBMET02583 0.222 0.007 DBMET02585 | ||
| 0.579 | 0.004 | 0.579 | 5 Hydroxytryptamine 1F antagonist | 0.183 0.012 DBMET02583 0.384 0.005 DBMET02585 | ||
| 0.409 | 0.002 | 0.427 | 5 Hydroxytryptamine 3E antagonist | 0.22 0.036 DBMET02583 0.427 0.002 DBMET02585 | DBMET02585 | |
| 0.275 | 0.001 | 0.275 | 5 Hydroxytryptamine 6 agonist | 0.051 0.004 DBMET02583 0.12 0.002 DBMET02585 | ||
| 0.311 | 0.066 | 0.38 | 5 Hydroxytryptamine release stimulant | 0.211 0.113 DBMET02583 0.38 0.05 DBMET02585 | DBMET02585 | |
| 0.298 | 0.06 | 0.319 | Insulysin inhibitor | 0.319 0.048 DBMET02583 0.289 0.066 DBMET02585 | DBMET02583 | |
| 0.259 | 0.024 | 0.259 | 5 Hydroxytryptamine antagonist | 0.128 0.061 DBMET02585 | ||
| 0.246 | 0.013 | 0.246 | 5 Hydroxytryptamine 1 antagonist | 0.076 0.049 DBMET02585 | ||
| 0.233 | 0.003 | 0.233 | 5 Hydroxytryptamine 1F agonist | 0.046 0.005 DBMET02583 0.049 0.005 DBMET02585 | ||
| 0.221 | 0.006 | 0.221 | Prolactin inhibitor | 0.147 0.023 DBMET02583 0.215 0.007 DBMET02585 | ||
| 0.249 | 0.039 | 0.338 | Anticoagulant | 0.308 0.027 DBMET02583 0.142 0.087 DBMET02585 0.338 0.023 DBMET02584 | DBMET02584 | |
| 0.265 | 0.056 | 0.393 | Interleukin antagonist | 0.393 0.032 DBMET02583 0.242 0.064 DBMET02585 0.217 0.075 DBMET02584 | DBMET02583 | |
| 0.202 | 0.004 | 0.202 | 5 Hydroxytryptamine 3 agonist | 0.069 0.037 DBMET02583 0.096 0.017 DBMET02585 | ||
| 0.262 | 0.074 | 0.262 | Cardiotonic | |||
| 0.21 | 0.025 | 0.256 | Cyclin-dependent kinase 1 inhibitor | 0.131 0.049 DBMET02583 0.256 0.016 DBMET02585 | DBMET02585 | |
| 0.193 | 0.018 | 0.193 | 5 Hydroxytryptamine 2C antagonist | 0.095 0.049 DBMET02585 | ||
| 0.181 | 0.007 | 0.197 | Histamine N-methyltransferase inhibitor | 0.197 0.005 DBMET02585 | DBMET02585 | |
| 0.182 | 0.028 | 0.182 | Cyclin-dependent kinase 2 inhibitor | 0.12 0.053 DBMET02583 0.126 0.049 DBMET02585 | ||
| 0.187 | 0.034 | 0.187 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.16 | 0.009 | 0.169 | Plasmin inhibitor | 0.169 0.009 DBMET02583 0.048 0.033 DBMET02585 0.048 0.033 DBMET02584 | DBMET02583 | |
| 0.171 | 0.024 | 0.171 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.252 | 0.105 | 0.252 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.233 0.122 DBMET02585 | ||
| 0.174 | 0.029 | 0.183 | MAP kinase kinase 4 inhibitor | 0.177 0.027 DBMET02583 0.183 0.022 DBMET02585 0.138 0.089 DBMET02584 | DBMET02585 | |
| 0.138 | 0.014 | 0.176 | Carbonic anhydrase VA inhibitor | 0.164 0.008 DBMET02583 0.176 0.007 DBMET02585 | DBMET02585 | |
| 0.145 | 0.021 | 0.146 | Factor V inhibitor | 0.146 0.02 DBMET02583 0.108 0.054 DBMET02585 0.115 0.045 DBMET02584 | DBMET02583 | |
| 0.131 | 0.008 | 0.131 | Beta 3 adrenoreceptor antagonist | 0.073 0.03 DBMET02583 0.109 0.012 DBMET02585 | ||
| 0.13 | 0.009 | 0.13 | 5 Hydroxytryptamine 6 antagonist | 0.092 0.017 DBMET02585 | ||
| 0.138 | 0.017 | 0.187 | Carbonic anhydrase V inhibitor | 0.172 0.01 DBMET02583 0.187 0.008 DBMET02585 | DBMET02585 | |
| 0.138 | 0.018 | 0.138 | Adrenaline agonist | 0.111 0.03 DBMET02583 0.121 0.025 DBMET02585 | ||
| 0.133 | 0.018 | 0.139 | Factor XII inhibitor | 0.139 0.016 DBMET02583 0.099 0.038 DBMET02585 0.082 0.062 DBMET02584 | DBMET02583 | |
| 0.124 | 0.017 | 0.124 | Thrombin inhibitor | 0.114 0.02 DBMET02583 0.079 0.042 DBMET02585 0.081 0.04 DBMET02584 | ||
| 0.113 | 0.006 | 0.118 | Factor VII inhibitor | 0.118 0.005 DBMET02583 0.031 0.02 DBMET02585 0.029 0.022 DBMET02584 | DBMET02583 | |
| 0.143 | 0.036 | 0.196 | Cyclin-dependent kinase 9 inhibitor | 0.196 0.023 DBMET02585 | DBMET02585 | |
| 0.123 | 0.022 | 0.123 | Somatostatin 1 agonist | 0.102 0.032 DBMET02583 0.117 0.025 DBMET02585 0.071 0.063 DBMET02584 | ||
| 0.108 | 0.011 | 0.112 | Factor VIIa inhibitor | 0.112 0.01 DBMET02583 0.038 0.027 DBMET02585 | DBMET02583 | |
| 0.109 | 0.013 | 0.119 | Plasminogen activator inhibitor | 0.119 0.011 DBMET02583 0.052 0.046 DBMET02585 | DBMET02583 | |
| 0.151 | 0.056 | 0.239 | Cyclin-dependent kinase inhibitor | 0.239 0.029 DBMET02585 | DBMET02585 | |
| 0.102 | 0.01 | 0.102 | Factor X inhibitor | 0.081 0.013 DBMET02583 0.066 0.017 DBMET02585 | ||
| 0.106 | 0.016 | 0.126 | CC chemokine 5 receptor agonist | 0.083 0.054 DBMET02583 0.126 0.007 DBMET02585 | DBMET02585 | |
| 0.129 | 0.039 | 0.242 | Carbonic anhydrase III inhibitor | 0.134 0.035 DBMET02583 0.242 0.01 DBMET02585 0.085 0.083 DBMET02584 | DBMET02585 | |
| 0.094 | 0.005 | 0.094 | 5 Hydroxytryptamine 3B antagonist | 0.036 0.025 DBMET02585 | ||
| 0.114 | 0.027 | 0.114 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.11 | 0.026 | 0.136 | Myeloperoxidase inhibitor | 0.136 0.014 DBMET02585 | DBMET02585 | |
| 0.098 | 0.015 | 0.098 | ZAP-70 protein tyrosine kinase inhibitor | 0.097 0.016 DBMET02583 | ||
| 0.095 | 0.017 | 0.154 | Carbonic anhydrase VB inhibitor | 0.072 0.027 DBMET02583 0.154 0.008 DBMET02585 | DBMET02585 | |
| 0.1 | 0.023 | 0.1 | Ca(v)3.1 blocker | 0.079 0.063 DBMET02583 | ||
| 0.124 | 0.055 | 0.153 | Alpha 2b adrenoreceptor antagonist | 0.153 0.037 DBMET02585 | DBMET02585 | |
| 0.092 | 0.027 | 0.332 | I kappa B kinase 1 inhibitor | 0.066 0.054 DBMET02583 0.332 0.004 DBMET02585 | DBMET02585 | |
| 0.158 | 0.094 | 0.226 | Lipocortins synthesis antagonist | 0.226 0.042 DBMET02583 0.167 0.084 DBMET02585 0.181 0.07 DBMET02584 | DBMET02583 | |
| 0.098 | 0.034 | 0.098 | Protein kinase B gamma inhibitor | |||
| 0.078 | 0.022 | 0.095 | Urokinase inhibitor | 0.095 0.018 DBMET02583 | DBMET02583 | |
| 0.08 | 0.027 | 0.085 | Trypsin inhibitor | 0.085 0.024 DBMET02583 0.06 0.048 DBMET02585 | DBMET02583 | |
| 0.082 | 0.03 | 0.126 | Neutrophil collagenase inhibitor | 0.126 0.016 DBMET02583 0.064 0.046 DBMET02585 | DBMET02583 | |
| 0.072 | 0.02 | 0.072 | Factor Xa inhibitor | 0.046 0.032 DBMET02585 0.051 0.028 DBMET02584 | ||
| 0.08 | 0.031 | 0.08 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.168 | 0.12 | 0.168 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.061 | 0.013 | 0.061 | Glycine transporter 1 inhibitor | |||
| 0.109 | 0.063 | 0.109 | Protein kinase C gamma inhibitor | 0.099 0.078 DBMET02585 | ||
| 0.078 | 0.033 | 0.078 | Bcl2 antagonist | |||
| 0.074 | 0.034 | 0.074 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.064 | 0.032 | 0.064 | Alpha 1 adrenoreceptor agonist | |||
| 0.058 | 0.026 | 0.058 | 5 Hydroxytryptamine 4 antagonist | 0.05 0.037 DBMET02585 | ||
| 0.043 | 0.011 | 0.043 | Melatonin receptor 1A agonist | 0.031 0.028 DBMET02583 0.038 0.015 DBMET02585 | ||
| 0.058 | 0.026 | 0.058 | Vanilloid 2 antagonist | 0.051 0.04 DBMET02585 | ||
| 0.042 | 0.011 | 0.042 | GHS receptor antagonist | 0.038 0.014 DBMET02583 0.037 0.015 DBMET02585 | ||
| 0.077 | 0.046 | 0.116 | Metalloproteinase-9 inhibitor | 0.116 0.026 DBMET02583 0.079 0.045 DBMET02585 | DBMET02583 | |
| 0.04 | 0.009 | 0.043 | Urotensin II agonist | 0.043 0.008 DBMET02585 | DBMET02585 | |
| 0.046 | 0.017 | 0.048 | Bombesin 1 receptor antagonist | 0.038 0.025 DBMET02583 0.048 0.015 DBMET02585 | DBMET02585 | |
| 0.081 | 0.052 | 0.125 | Metalloproteinase-2 inhibitor | 0.125 0.027 DBMET02583 0.082 0.05 DBMET02585 | DBMET02583 | |
| 0.086 | 0.059 | 0.086 | Alpha 2 adrenoreceptor antagonist | |||
| 0.056 | 0.031 | 0.139 | Thromboxane A2 antagonist | 0.139 0.004 DBMET02583 | DBMET02583 | |
| 0.066 | 0.042 | 0.066 | Purinergic P2 antagonist | 0.063 0.045 DBMET02583 | ||
| 0.274 | 0.25 | 0.301 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.301 0.211 DBMET02585 | DBMET02585 | |
| 0.075 | 0.052 | 0.075 | Alpha 2a adrenoreceptor antagonist | |||
| 0.151 | 0.13 | 0.151 | Focal adhesion kinase 2 inhibitor | |||
| 0.127 | 0.106 | 0.293 | Phospholipase A2 inhibitor | 0.293 0.015 DBMET02583 0.225 0.031 DBMET02584 | DBMET02583 | |
| 0.046 | 0.027 | 0.049 | Beta adrenoreceptor agonist | 0.046 0.029 DBMET02583 0.049 0.019 DBMET02585 | DBMET02585 | |
| 0.062 | 0.042 | 0.072 | Beta 2 adrenoreceptor agonist | 0.072 0.016 DBMET02585 | DBMET02585 | |
| 0.046 | 0.026 | 0.06 | Cholecystokinin antagonist | 0.06 0.019 DBMET02583 0.041 0.029 DBMET02585 | DBMET02583 | |
| 0.098 | 0.079 | 0.125 | Nav1.4 sodium channel blocker | 0.125 0.048 DBMET02583 0.094 0.086 DBMET02585 | DBMET02583 | |
| 0.05 | 0.03 | 0.05 | Bombesin antagonist | 0.049 0.03 DBMET02583 0.048 0.033 DBMET02585 | ||
| 0.041 | 0.021 | 0.041 | Somatostatin 4 agonist | 0.037 0.025 DBMET02585 | ||
| 0.06 | 0.041 | 0.063 | Bombesin 1 receptor agonist | 0.056 0.046 DBMET02583 0.063 0.037 DBMET02585 | DBMET02585 | |
| 0.056 | 0.037 | 0.057 | Bombesin 3 receptor antagonist | 0.057 0.036 DBMET02583 | DBMET02583 | |
| 0.05 | 0.031 | 0.05 | Glycine transporter inhibitor | |||
| 0.055 | 0.036 | 0.149 | Thromboxane antagonist | 0.149 0.005 DBMET02583 | DBMET02583 | |
| 0.107 | 0.088 | 0.107 | MAP kinase 12 inhibitor | |||
| 0.059 | 0.041 | 0.082 | CDK9/cyclin T1 inhibitor | 0.082 0.025 DBMET02585 | DBMET02585 | |
| 0.066 | 0.049 | 0.066 | Alpha adrenoreceptor agonist | |||
| 0.04 | 0.024 | 0.045 | Cholecystokinin A antagonist | 0.045 0.022 DBMET02583 0.037 0.026 DBMET02585 | DBMET02583 | |
| 0.058 | 0.042 | 0.091 | Carbonic anhydrase stimulant | 0.091 0.021 DBMET02583 0.068 0.033 DBMET02585 | DBMET02583 | |
| 0.044 | 0.029 | 0.056 | Histamine H2 receptor agonist | 0.056 0.017 DBMET02585 | DBMET02585 | |
| 0.022 | 0.008 | 0.028 | Follicle-stimulating hormone antagonist | 0.023 0.008 DBMET02583 0.028 0.005 DBMET02585 | DBMET02585 | |
| 0.046 | 0.032 | 0.046 | 5 Hydroxytryptamine 1A agonist | |||
| 0.043 | 0.029 | 0.043 | GHS receptor agonist | 0.041 0.032 DBMET02585 | ||
| 0.039 | 0.027 | 0.043 | Somatostatin 1 antagonist | 0.043 0.024 DBMET02585 | DBMET02585 | |
| 0.034 | 0.022 | 0.039 | Trypsin I inhibitor | 0.039 0.018 DBMET02583 | DBMET02583 | |
| 0.053 | 0.042 | 0.053 | Epithelial sodium channel blocker | |||
| 0.038 | 0.028 | 0.038 | Histone deacetylase 9 inhibitor | 0.038 0.03 DBMET02585 | ||
| 0.047 | 0.038 | 0.101 | Prostaglandin E2 antagonist | 0.101 0.014 DBMET02583 | DBMET02583 | |
| 0.053 | 0.045 | 0.059 | 5 Hydroxytryptamine 7 agonist | 0.059 0.033 DBMET02585 | DBMET02585 | |
| 0.033 | 0.025 | 0.033 | Growth hormone secretagogue receptor agonist | 0.032 0.026 DBMET02585 | ||
| 0.057 | 0.049 | 0.071 | 5 Hydroxytryptamine uptake inhibitor | 0.071 0.038 DBMET02585 | DBMET02585 | |
| 0.057 | 0.05 | 0.057 | Bcl-xL inhibitor | |||
| 0.047 | 0.041 | 0.077 | Beta 2 adrenoreceptor antagonist | 0.077 0.013 DBMET02585 | DBMET02585 | |
| 0.061 | 0.055 | 0.096 | Beta adrenoreceptor antagonist | 0.096 0.018 DBMET02585 | DBMET02585 | |
| 0.032 | 0.026 | 0.043 | Purinergic P2Y2 antagonist | 0.043 0.014 DBMET02583 0.031 0.028 DBMET02584 | DBMET02583 | |
| 0.032 | 0.027 | 0.032 | Growth hormone secretagogue receptor antagonist | |||
| 0.051 | 0.045 | 0.059 | Beta 1 adrenoreceptor antagonist | 0.059 0.037 DBMET02585 | DBMET02585 | |
| 0.057 | 0.052 | 0.09 | Prostaglandin F2 alpha antagonist | 0.09 0.016 DBMET02583 0.056 0.053 DBMET02584 | DBMET02583 | |
| 0.031 | 0.027 | 0.031 | Vanilloid 4 antagonist | |||
| 0.231 | 0.228 | 0.335 | Calcium channel L-type activator | 0.335 0.129 DBMET02583 0.253 0.202 DBMET02585 | DBMET02583 | |
| 0.027 | 0.024 | 0.035 | Cholecystokinin B antagonist | 0.035 0.018 DBMET02583 | DBMET02583 | |
| 0.02 | 0.018 | 0.025 | Follicle-stimulating hormone agonist | 0.025 0.012 DBMET02585 | DBMET02585 | |
| 0.103 | 0.101 | 0.103 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.029 | 0.028 | 0.043 | Plasma kallikrein inhibitor | 0.043 0.016 DBMET02583 | DBMET02583 | |
| 0.127 | 0.125 | 0.127 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.033 | 0.033 | 0.038 | Cholecystokinin B agonist | 0.038 0.026 DBMET02583 0.035 0.03 DBMET02585 | DBMET02583 | |
| 0.088 | 0.088 | 0.204 | Carbonic anhydrase XV inhibitor | 0.204 0.018 DBMET02585 | DBMET02585 | |
| 0.205 | 0.209 | 0.214 | 15-Lipoxygenase inhibitor | 0.214 0.197 DBMET02583 | DBMET02583 | |
| 0.03 | 0.037 | 0.039 | Carbonic anhydrase I stimulant | 0.039 0.025 DBMET02583 | DBMET02583 | |
| 0.035 | 0.043 | 0.047 | Endothelin-converting enzyme inhibitor | 0.047 0.033 DBMET02583 | DBMET02583 | |
| 0.007 | 0.016 | 0.01 | Beta 3 adrenoreceptor agonist | 0.01 0.009 DBMET02583 | DBMET02583 | |
| 0.038 | 0.048 | 0.051 | Kallikrein inhibitor | 0.051 0.029 DBMET02583 | DBMET02583 | |
| 0.052 | 0.064 | 0.077 | Matrix metalloproteinase inhibitor | 0.077 0.039 DBMET02583 | DBMET02583 | |
| 0.044 | 0.058 | 0.066 | Matrix metalloproteinase (membrane-type) inhibitor | 0.066 0.027 DBMET02583 | DBMET02583 | |
| 0.087 | 0.101 | 0.093 | 5 Hydroxytryptamine 2B antagonist | 0.093 0.092 DBMET02585 | DBMET02585 | |
| 0.027 | 0.044 | 0.061 | p53 inhibitor | 0.061 0.008 DBMET02583 | DBMET02583 | |
| 0.131 | 0.154 | 0.268 | Anticonvulsant | 0.153 0.125 DBMET02583 0.268 0.05 DBMET02585 | DBMET02585 | |
| 0.024 | 0.053 | 0.034 | AMPA receptor agonist | 0.034 0.028 DBMET02583 | DBMET02583 | |
| 0.061 | 0.093 | 0.173 | Carbonic anhydrase VI inhibitor | 0.173 0.017 DBMET02585 | DBMET02585 | |
| 0.075 | 0.11 | 0.149 | Electrolyte absorption antagonist | 0.149 0.02 DBMET02583 0.102 0.055 DBMET02585 | DBMET02583 | |
| 0.014 | 0.05 | 0.046 | Prostaglandin EP3 antagonist | 0.046 0.011 DBMET02583 | DBMET02583 | |
| 0.127 | 0.164 | 0.223 | Platelet aggregation inhibitor | 0.223 0.066 DBMET02583 | DBMET02583 | |
| 0.03 | 0.069 | 0.095 | Carbonic anhydrase I inhibitor | 0.095 0.02 DBMET02585 | DBMET02585 | |
| 0.089 | 0.129 | 0.19 | Interleukin 8 antagonist | 0.19 0.015 DBMET02583 0.1 0.096 DBMET02585 | DBMET02583 | |
| 0.163 | 0.205 | 0.307 | Gastrin inhibitor | 0.307 0.028 DBMET02583 0.197 0.153 DBMET02585 0.185 0.171 DBMET02584 | DBMET02583 | |
| 0.076 | 0.12 | 0.295 | AMP-activated protein kinase stimulant | 0.146 0.031 DBMET02583 0.295 0.005 DBMET02584 | DBMET02584 | |
| 0.036 | 0.082 | 0.05 | Bombesin 2 receptor antagonist | 0.05 0.033 DBMET02583 | DBMET02583 | |
| 0.028 | 0.076 | 0.091 | Carbonic anhydrase II inhibitor | 0.091 0.021 DBMET02585 | DBMET02585 | |
| 0.068 | 0.117 | 0.084 | Phosphodiesterase 7B inhibitor | 0.084 0.08 DBMET02585 | DBMET02585 | |
| 0.028 | 0.078 | 0.373 | Prostaglandin antagonist | 0.373 0.004 DBMET02583 | DBMET02583 | |
| 0.022 | 0.073 | 0.047 | Purinergic P2Y antagonist | 0.047 0.029 DBMET02583 | DBMET02583 | |
| 0.075 | 0.13 | 0.102 | Phosphodiesterase 6D inhibitor | 0.102 0.048 DBMET02585 | DBMET02585 | |
| 0.007 | 0.065 | 0.033 | Prostaglandin H2 antagonist | 0.033 0.01 DBMET02583 | DBMET02583 | |
| 0.03 | 0.092 | 0.102 | Carbonic anhydrase inhibitor | 0.102 0.026 DBMET02585 | DBMET02585 | |
| 0.022 | 0.084 | 0.044 | Substance P antagonist | 0.044 0.022 DBMET02585 | DBMET02585 | |
| 0.13 | 0.193 | 0.15 | Growth factor agonist | 0.15 0.14 DBMET02585 | DBMET02585 | |
| 0.012 | 0.075 | 0.039 | Prostaglandin EP4 antagonist | 0.039 0.011 DBMET02583 | DBMET02583 | |
| 0.028 | 0.091 | 0.066 | Mineralocorticoid receptor antagonist | 0.066 0.016 DBMET02585 | DBMET02585 | |
| 0.01 | 0.077 | 0.027 | Endothelin receptor antagonist | 0.027 0.021 DBMET02583 | DBMET02583 | |
| 0.015 | 0.085 | 0.064 | Carbonic anhydrase IV inhibitor | 0.064 0.017 DBMET02585 | DBMET02585 | |
| 0.026 | 0.098 | 0.045 | Neurokinin antagonist | 0.045 0.041 DBMET02585 | DBMET02585 | |
| 0.023 | 0.097 | 0.05 | AMPA 4 receptor antagonist | 0.05 0.015 DBMET02583 | DBMET02583 | |
| 0.024 | 0.107 | 0.101 | Prostaglandin EP2 antagonist | 0.101 0.019 DBMET02583 0.052 0.049 DBMET02584 | DBMET02583 | |
| 0.176 | 0.268 | 0.283 | Analgesic | 0.283 0.155 DBMET02585 | DBMET02585 | |
| 0.055 | 0.148 | 0.08 | Aminoacyl-tRNA synthetase inhibitor | 0.08 0.077 DBMET02583 | DBMET02583 | |
| 0.033 | 0.131 | 0.073 | Phenylalanine 4-hydroxylase inhibitor | 0.073 0.043 DBMET02583 | DBMET02583 | |
| 0.15 | 0.25 | 0.54 | Antithrombotic | 0.283 0.1 DBMET02583 0.54 0.024 DBMET02584 | DBMET02584 | |
| 0.025 | 0.13 | 0.077 | Carnitine palmitoyltransferase 1B inhibitor | 0.077 0.008 DBMET02583 | DBMET02583 | |
| 0.106 | 0.211 | 0.33 | Platelet antagonist | 0.293 0.055 DBMET02583 0.33 0.043 DBMET02584 | DBMET02584 | |
| 0.009 | 0.115 | 0.031 | HCV NS5B polymerase inhibitor | 0.031 0.022 DBMET02583 | DBMET02583 | |
| 0.008 | 0.115 | 0.046 | GP IIb/IIIa receptor antagonist | 0.046 0.036 DBMET02583 | DBMET02583 | |
| 0.004 | 0.113 | 0.025 | AMPA 1 receptor antagonist | 0.025 0.023 DBMET02583 | DBMET02583 | |
| 0.067 | 0.178 | 0.14 | Adenylate kinase inhibitor | 0.14 0.031 DBMET02583 | DBMET02583 | |
| 0.05 | 0.162 | 0.142 | Cyclin-dependent kinase 5 inhibitor | 0.142 0.045 DBMET02585 | DBMET02585 | |
| 0.01 | 0.126 | 0.074 | Carbonic anhydrase IX inhibitor | 0.074 0.03 DBMET02585 | DBMET02585 | |
| 0.098 | 0.215 | 0.155 | CF transmembrane conductance regulator agonist | 0.155 0.068 DBMET02585 | DBMET02585 | |
| 0.03 | 0.15 | 0.056 | Thromboxane synthase inhibitor | 0.056 0.035 DBMET02583 | DBMET02583 | |
| 0.01 | 0.131 | 0.051 | Carbonic anhydrase XII inhibitor | 0.051 0.038 DBMET02585 | DBMET02585 | |
| 0.031 | 0.153 | 0.108 | Carbonic anhydrase XIII inhibitor | 0.108 0.034 DBMET02585 | DBMET02585 | |
| 0.015 | 0.138 | 0.042 | Macrophage elastase inhibitor | 0.042 0.031 DBMET02583 | DBMET02583 | |
| 0.027 | 0.152 | 0.06 | Collagenase 3 inhibitor | 0.06 0.041 DBMET02583 | DBMET02583 | |
| 0.05 | 0.178 | 0.093 | GABA B receptor agonist | 0.093 0.022 DBMET02583 | DBMET02583 | |
| 0.085 | 0.217 | 0.138 | Growth hormone agonist | 0.138 0.098 DBMET02583 | DBMET02583 | |
| 0.038 | 0.178 | 0.102 | I kappa B kinase inhibitor | 0.102 0.037 DBMET02585 | DBMET02585 | |
| 0.009 | 0.151 | 0.046 | Free fatty acid receptor 1 antagonist | 0.046 0.011 DBMET02583 | DBMET02583 | |
| 0.015 | 0.16 | 0.032 | RNA-directed RNA polymerase inhibitor | 0.032 0.028 DBMET02583 | DBMET02583 | |
| 0.066 | 0.215 | 0.165 | Interleukin 4 antagonist | 0.149 0.05 DBMET02583 0.165 0.038 DBMET02584 | DBMET02584 | |
| 0.03 | 0.179 | 0.063 | I kappa B kinase 2 inhibitor | 0.063 0.042 DBMET02585 | DBMET02585 | |
| 0.087 | 0.237 | 0.146 | Aldehyde oxidase inhibitor | 0.146 0.142 DBMET02585 | DBMET02585 | |
| 0.008 | 0.16 | 0.047 | Kainate receptor antagonist | 0.047 0.023 DBMET02583 | DBMET02583 | |
| 0.004 | 0.175 | 0.154 | Prostaglandin D2 antagonist | 0.154 0.004 DBMET02583 | DBMET02583 | |
| 0.043 | 0.223 | 0.082 | Glutathione S-transferase inhibitor | 0.082 0.058 DBMET02583 | DBMET02583 | |
| 0.006 | 0.195 | 0.049 | Kinesin antagonist | 0.049 0.017 DBMET02585 | DBMET02585 | |
| 0.006 | 0.195 | 0.049 | Kinesin-like protein 1 inhibitor | 0.049 0.017 DBMET02585 | DBMET02585 | |
| 0.073 | 0.265 | 0.342 | Platelet adhesion inhibitor | 0.143 0.113 DBMET02583 0.342 0.022 DBMET02584 | DBMET02584 | |
| 0.015 | 0.221 | 0.035 | Retinoid X alpha receptor antagonist | 0.035 0.023 DBMET02583 | DBMET02583 | |
| 0.016 | 0.237 | 0.038 | Retinoid X receptor antagonist | 0.038 0.027 DBMET02583 | DBMET02583 | |
| 0.038 | 0.265 | 0.085 | Interleukin 1 beta converting enzyme inhibitor | 0.085 0.08 DBMET02583 | DBMET02583 | |
| 0.114 | 0.347 | 0.349 | Sodium/bile acid cotransporter inhibitor | 0.349 0.04 DBMET02583 0.23 0.15 DBMET02584 | DBMET02583 | |
| 0.022 | 0.257 | 0.092 | CDK1/cyclin B1 inhibitor | 0.092 0.032 DBMET02585 | DBMET02585 | |
| 0.063 | 0.316 | 0.143 | DNA methylase inhibitor | 0.143 0.124 DBMET02584 | DBMET02584 | |
| 0.051 | 0.316 | 0.15 | Diuretic | 0.15 0.077 DBMET02585 | DBMET02585 | |
| 0.031 | 0.298 | 0.133 | Alkylator | 0.133 0.057 DBMET02584 | DBMET02584 | |
| 0.043 | 0.314 | 0.084 | ABCA1 expression enhancer | 0.084 0.078 DBMET02583 | DBMET02583 | |
| 0.032 | 0.303 | 0.101 | GABA C receptor agonist | 0.101 0.066 DBMET02583 | DBMET02583 | |
| 0.052 | 0.325 | 0.164 | Insulin sensitizer | 0.164 0.114 DBMET02583 | DBMET02583 | |
| 0.029 | 0.305 | 0.115 | Bronchodilator | 0.115 0.048 DBMET02585 | DBMET02585 | |
| 0.086 | 0.365 | 0.241 | Angiogenesis inhibitor | 0.241 0.13 DBMET02584 | DBMET02584 | |
| 0.017 | 0.3 | 0.154 | Lipase inhibitor | 0.154 0.009 DBMET02585 | DBMET02585 | |
| 0.017 | 0.312 | 0.096 | Protein-tyrosine phosphatase 1B inhibitor | 0.096 0.082 DBMET02584 | DBMET02584 | |
| 0.098 | 0.402 | 0.138 | Heat shock protein 70 antagonist | 0.138 0.085 DBMET02585 | DBMET02585 | |
| 0.032 | 0.342 | 0.161 | Beta glucuronidase inhibitor | 0.161 0.02 DBMET02584 | DBMET02584 | |
| 0.039 | 0.367 | 0.116 | DOPA decarboxylase inhibitor | 0.116 0.05 DBMET02583 | DBMET02583 | |
| 0.071 | 0.406 | 0.432 | Hypoglycemic | 0.203 0.11 DBMET02583 0.432 0.023 DBMET02584 | DBMET02584 | |
| 0.083 | 0.437 | 0.178 | Cyclin-dependent kinase 3 inhibitor | 0.178 0.05 DBMET02585 | DBMET02585 | |
| 0.03 | 0.391 | 0.081 | Triose-phosphate isomerase inhibitor | 0.081 0.074 DBMET02584 | DBMET02584 | |
| 0.082 | 0.444 | 0.311 | Toll-Like receptor 7 agonist | 0.311 0.103 DBMET02583 | DBMET02583 | |
| 0.007 | 0.37 | 0.031 | Peroxisome proliferator-activated receptor delta antagonist | 0.031 0.028 DBMET02583 | DBMET02583 | |
| 0.086 | 0.452 | 0.13 | CC chemokine 6 receptor antagonist | 0.13 0.07 DBMET02584 | DBMET02584 | |
| 0.079 | 0.451 | 0.309 | Toll-Like receptor agonist | 0.309 0.106 DBMET02583 | DBMET02583 | |
| 0.017 | 0.411 | 0.092 | Topoisomerase I inhibitor | 0.092 0.077 DBMET02584 | DBMET02584 | |
| 0.026 | 0.422 | 0.192 | Lipid peroxidase inhibitor | 0.192 0.045 DBMET02584 | DBMET02584 | |
| 0.032 | 0.436 | 0.175 | Cell wall synthesis inhibitor | 0.175 0.044 DBMET02584 | DBMET02584 | |
| 0.032 | 0.448 | 0.379 | Immunostimulant | 0.379 0.056 DBMET02584 | DBMET02584 | |
| 0.054 | 0.472 | 0.417 | Immunosuppressant | 0.417 0.057 DBMET02584 | DBMET02584 | |
| 0.021 | 0.44 | 0.121 | Protein-tyrosine phosphatase inhibitor | 0.121 0.112 DBMET02584 | DBMET02584 | |
| 0.02 | 0.447 | 0.12 | Cyclooxygenase 2 inhibitor | 0.12 0.079 DBMET02585 | DBMET02585 | |
| 0.023 | 0.452 | 0.204 | Thrombolytic | 0.204 0.05 DBMET02584 | DBMET02584 | |
| 0.006 | 0.439 | 0.063 | Peroxisome proliferator-activated receptor gamma agonist | 0.063 0.055 DBMET02583 | DBMET02583 | |
| 0.008 | 0.449 | 0.284 | Selectin antagonist | 0.284 0.006 DBMET02584 | DBMET02584 | |
| 0.037 | 0.484 | 0.262 | Alpha-glucosidase inhibitor | 0.262 0.181 DBMET02584 | DBMET02584 | |
| 0.023 | 0.475 | 0.127 | Cyclooxygenase inhibitor | 0.127 0.091 DBMET02583 0.113 0.108 DBMET02585 0.113 0.108 DBMET02584 | DBMET02583 | |
| 0.026 | 0.483 | 0.447 | Angiogenesis stimulant | 0.447 0.016 DBMET02584 | DBMET02584 | |
| 0.073 | 0.538 | 0.337 | Apoptosis antagonist | 0.337 0.062 DBMET02584 | DBMET02584 | |
| 0.018 | 0.483 | 0.119 | Cyclooxygenase 1 inhibitor | 0.119 0.081 DBMET02583 0.104 0.096 DBMET02584 | DBMET02583 | |
| 0.02 | 0.5 | 0.062 | DNA helicase inhibitor | 0.062 0.024 DBMET02583 | DBMET02583 | |
| 0.02 | 0.516 | 0.105 | Multidrug resistance-associated protein 1 inhibitor | 0.105 0.07 DBMET02584 | DBMET02584 | |
| 0.025 | 0.53 | 0.152 | Amylase inhibitor | 0.152 0.063 DBMET02584 | DBMET02584 | |
| 0.081 | 0.593 | 0.301 | Peptidyltransferase inhibitor | 0.301 0.024 DBMET02584 | DBMET02584 | |
| 0.029 | 0.548 | 0.151 | Hemostatic | 0.151 0.067 DBMET02584 | DBMET02584 | |
| 0.012 | 0.54 | 0.06 | Heparanase inhibitor | 0.06 0.022 DBMET02584 | DBMET02584 | |
| 0.027 | 0.559 | 0.154 | Vasodilator | 0.154 0.152 DBMET02584 | DBMET02584 | |
| 0.027 | 0.56 | 0.135 | Cyclooxygenase 3 inhibitor | 0.135 0.061 DBMET02584 | DBMET02584 | |
| 0.021 | 0.557 | 0.354 | Free radical scavenger | 0.354 0.038 DBMET02584 | DBMET02584 | |
| 0.012 | 0.568 | 0.047 | Glucose-6-phosphate translocase inhibitor | 0.047 0.045 DBMET02584 | DBMET02584 | |
| 0.027 | 0.595 | 0.222 | Tumour necrosis factor alpha release inhibitor | 0.222 0.092 DBMET02584 | DBMET02584 | |
| 0.025 | 0.593 | 0.22 | Non-steroidal antiinflammatory agent | 0.22 0.057 DBMET02584 | DBMET02584 | |
| 0.024 | 0.598 | 0.159 | Insulin secretagoues | 0.159 0.065 DBMET02584 | DBMET02584 | |
| 0.053 | 0.627 | 0.457 | Apoptosis agonist | 0.457 0.089 DBMET02584 | DBMET02584 | |
| 0.009 | 0.59 | 0.076 | Protein 50S ribosomal subunit inhibitor | 0.076 0.021 DBMET02584 | DBMET02584 | |
| 0.004 | 0.607 | 0.021 | Protein 30S ribosomal subunit inhibitor | 0.021 0.02 DBMET02584 | DBMET02584 | |
| 0.019 | 0.638 | 0.382 | Antioxidant | 0.382 0.038 DBMET02584 | DBMET02584 | |
| 0.037 | 0.664 | 0.334 | Immunomodulator | 0.334 0.066 DBMET02584 | DBMET02584 | |
| 0.021 | 0.649 | 0.152 | Toll-Like receptor 4 antagonist | 0.152 0.02 DBMET02584 | DBMET02584 | |
| 0.017 | 0.683 | 0.344 | Transcription factor NF kappa B inhibitor | 0.344 0.079 DBMET02584 | DBMET02584 | |
| 0.009 | 0.677 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.024 DBMET02584 | DBMET02584 | |
| 0.023 | 0.695 | 0.534 | Antibacterial | 0.534 0.032 DBMET02584 | DBMET02584 | |
| 0.029 | 0.704 | 0.273 | Hepatoprotectant | 0.273 0.038 DBMET02584 | DBMET02584 | |
| 0.008 | 0.761 | 0.049 | Antibiotic Aminoglycoside-like | 0.049 0.014 DBMET02584 | DBMET02584 | |
| 0.003 | 0.76 | 0.08 | Antineoplastic antibiotic | 0.08 0.057 DBMET02584 | DBMET02584 | |
| 0.022 | 0.79 | 0.092 | Transcription factor NF kappa B stimulant | 0.092 0.047 DBMET02584 | DBMET02584 | |
| 0.048 | 0.835 | 0.402 | Interleukin 2 agonist | 0.244 0.126 DBMET02583 0.402 0.027 DBMET02584 | DBMET02584 | |
| 0.018 | 0.806 | 0.535 | Cyclophilin D inhibitor | 0.248 0.216 DBMET02583 0.535 0.041 DBMET02584 | DBMET02584 | |
| 0.014 | 0.809 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.023 DBMET02584 | DBMET02584 | |
| 0.021 | 0.817 | 0.635 | Antiinflammatory | 0.635 0.044 DBMET02584 | DBMET02584 | |
| 0.009 | 0.811 | 0.225 | Nitric oxide antagonist | 0.225 0.059 DBMET02584 | DBMET02584 | |
| 0.024 | 0.869 | 0.125 | NOS3 expression enhancer | 0.125 0.106 DBMET02584 | DBMET02584 | |
| 0.007 | 0.866 | 0.107 | Cell adhesion inhibitor | 0.107 0.078 DBMET02584 | DBMET02584 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |